Enjoy complimentary customisation on priority with our Enterprise License!
The flow cytometry market size is projected to increase by USD 6.04 billion at a CAGR of 13.12% between 2022 and 2027. Market growth is influenced by several factors, notably the escalating expenditure on research and development (R&D), which drives innovation and technological advancements in flow cytometry. The expanding array of applications for flow cytometers across various sectors, including healthcare, biotechnology, and research, contributes significantly to market expansion. Furthermore, continuous technological advances in flow cytometry systems enhance their efficiency and capabilities, catering to evolving user requirements. These factors collectively foster a conducive environment for market growth, emphasizing the importance of R&D investment and technological innovation in driving the market forward.
Moreover, the market growth and forecasting report includes key player's detailed analyses of the competitive landscape of the market and information about 20 market companies, including Abbott Laboratories, Apogee Flow Systems Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., Miltenyi Biotec B.V. and Co. KG, Mindray Bio medical Electronics Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, Onchip Biotechnology Co. Ltd.Corp., Sartorius AG, Sony Group Corp., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Union Biometrica Inc. Additionally, Amphasys AG company offers flow cytometry such as Ampha X30.
For More Highlights About this Report, Download Free Sample in a Minute
The market is characterized by its ability to analyze multiparametric data in stem cell cultures using fluorescent-labeled antibodies and compounds. It aids in understanding stem cell behavior and control parameters, essential for biopharmaceutical research activities and diagnosing autoimmune disorders like AIDS. With advanced flow cytometer instruments and microfluidic flow cytometry, it offers precise analysis, complementing techniques such as Western blotting, immunohistochemistry, and microscopy in data analysis solutions. Further, flow cytometry-based cell sorters, coupled with fluorescent-labeled compounds, facilitate the operator's analytical process flow, offering precise and efficient cell sorting capabilities essential for various flow cytometry services and techniques involving the analysis and characterization of cells using specialized instruments. Our researchers analyzed the market research and growth data with 2022 as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage.
Increasing R&D investment emerges as a pivotal driver for the global market's expansion. Over the past decade, global R&D spending has shown a consistent upward trajectory. The rise in the occurrence of various ailments like Cancer, HIV/AIDS, and COVID-19, alongside conditions such as Immunodeficiency disorders and Infectious diseases, fuels the urgency to develop effective treatments such as PCR
Antibody-based testing, prompting heightened investment in the Biotechnology and Life science sectors.
Further, pharmaceutical entities prioritize R&D endeavors to enrich their product pipelines, catering to diverse therapeutic needs. A surge in R&D outlays is witnessed as companies strive to innovate and introduce novel drugs. The escalating demand for cutting-edge technologies underscores the significance of this market segment's growth in the foreseeable future.
The increasing level of process automation is the primary trend shaping the market growth. Automation is evident in nearly all laboratory processes, including flow cytometry. From using manual sample preparation and loading techniques earlier to now using instruments that are designed to prepare, load, and store samples for the process, the technology and level of automation have improved greatly over the past couple of decades. As these devices have digital interfaces and allow the storage of processed information, they reduce the human intervention required substantially.
Further, the integration of these instruments with other devices and processes can increase flexibility, allow continuous process flow for the samples, and reduce processing time and human supervision. Additionally, most instruments and devices used in a modern laboratory can be integrated into a digital ecosystem to enable seamless integration from one process to the next. This will allow for greater throughput, better accuracy, energy efficiency, reduced wastage of resources, and lower operating costs in the long run. Therefore, the global market is expected to witness high growth during the forecast period.
The inefficient distribution network is the major challenge that affects the market expansion. Most of the major manufacturers of flow cytometers are either American or German. On average, these vendors have manufacturing or sales units in 3-5 countries worldwide, which means that the countries that do not have a manufacturing or sales unit of these vendors will have to import the instrument from the closest country that does.
Thus, coupled with the complexities involved in the logistics of these instruments, leads to an inefficient distribution network. However, the introduction of e-commerce, and safe third-party logistics, are gradually helping manufacturers to overcome this hurdle. This will negatively impact the growth of the market during the forecast period.
The market share growth by the reagents and consumables segment will be significant during the forecast period. This product segment generated high sales revenue due to the significantly higher volume of sales and the short product replacement or replenishment cycle. The primary functions of these reagents and consumables include Cell separation, Cell detection, Blocking, Cell status analysis, Performance control, and Cell staining. Such factors will increase segment growth during the forecast period.
Get a glance at the market contribution of various segments Download the PDF Sample
The reagents and consumables segment was valued at USD 2.54 billion in 2017. The reagents or markers used to detect molecules and other proteins in cells through various methods usually have a life of one process and cannot be reused as they are absorbed into the cell body. This necessitates the use of new reagents and markers for a subsequent process. The rising number of diagnostic processes in healthcare facilities worldwide has led to a rise in demand for flow cytometry reagents, particularly in the detection of conditions such as cancer and HIV.
The pharmaceutical industry?segment will account for the largest share of this segment.? The pharmaceutical sector is experiencing rapid expansion worldwide, with a significant focus on developing personalized medicine, presenting lucrative opportunities for drug companies. This trend drives demand for advanced analytical tools like flow cytometers and consumables, facilitating pharmacodynamics, molecular, and genomic analyses, as well as drug delivery studies. Factors such as the presence of global and regional pharmaceutical firms, heightened R&D investments, and increasing demand for innovative technologies propel growth in the market within the pharmaceutical industry.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 35% to the growth of the global market during the forecast period.
Technavio's analysts have provided extensive insight into the market forecast, detailing the regional trends and drivers influencing the market's trajectory throughout the forecast period. The North American market is driven by factors like increasing disease prevalence, pharmaceutical company presence, drug development endeavors, and technology adoption. Outsourcing R&D to contract research organizations (CROs), rising healthcare spending, and a robust market players landscape further contribute to market growth. The region witnesses a surge in chronic and infectious diseases, prompting extensive research and drug development, thus boosting demand for advanced analytical tools like flow cytometers. Additionally, prominent pharmaceutical firms' focus on new drug molecules fuels market expansion by driving instrument demand.
The market forecasting report includes the adoption lifecycle of the market research and growth, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and trends strategies.
Global Market Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Market analysis and report of qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market research report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017-2027
The market is experiencing significant advancements driven by hospitals, clinical testing laboratories, and contract research organizations (CROs). With a focus on drug discovery services and cellular diagnostics, innovators are leveraging flow cytometry techniques to analyze immune cells for conditions like leukemia and lymphoma. Companies like FlowMetric Life Sciences and Flow Contract Sites Laboratory offer flow cytometry analysis services utilizing flow cytometry instruments and liquid handling robotics. These technologies enable precise fluorochrome combinations and cell-based flow cytometry, enhancing drug development activities and aiding in the diagnosis of diseases such as tuberculosis and sexually transmitted diseases.
Further, the market encompasses a wide array of offerings, including software, reagents & consumables, and accessories essential for precise analysis. Innovations in flow cytometry technique by industry leaders and contract service providers are driving advancements in cell line development and flow cytometric services. With the integration of digital signal processing and point-of-care diagnostics, flow cytometry enables rapid and accurate analysis. Additionally, bead-based assays are gaining prominence in clinical testing labs, offering versatile solutions for various research and diagnostic applications. These developments highlight the evolving landscape of flow cytometry and its pivotal role in biomedical research and healthcare.
Market Scope |
|
Report Coverage |
Details |
Page number |
169 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 13.12% |
Market growth 2023-2027 |
USD 6.04 billion |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
12.09 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 35% |
Key countries |
US, Canada, UK, Germany, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Agilent Technologies Inc., Amphasys AG, Apogee Flow Systems Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Cytek Biosciences Inc., Danaher Corp., DiaSorin SpA, Enzo Biochem Inc., Miltenyi Biotec B.V. and Co. KG, Mindray Bio medical Electronics Co. Ltd, OLS OMNI Life Science GmbH and Co. KG, Onchip Biotechnology Co. Ltd.Corp., Sartorius AG, Sony Group Corp., Stratedigm Inc., Sysmex Corp., Thermo Fisher Scientific Inc., and Union Biometrica Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.